» Articles » PMID: 19698858

Thromboelastometry-guided Administration of Fibrinogen Concentrate for the Treatment of Excessive Intraoperative Bleeding in Thoracoabdominal Aortic Aneurysm Surgery

Overview
Date 2009 Aug 25
PMID 19698858
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Thoracoabdominal aortic aneurysm operations are associated with extensive blood loss and high requirements for allogeneic blood product transfusion. We assessed the efficacy of intraoperative post-cardiopulmonary bypass administration of fibrinogen concentrate in elective thoracoabdominal aortic aneurysm surgery.

Methods: In a retrospective group (group A, n = 12) of patients undergoing elective thoracoabdominal aortic aneurysm surgery, clinically relevant diffuse bleeding after weaning from cardiopulmonary bypass was treated with allogeneic blood products (platelet concentrates, followed by fresh frozen plasma) according to a predetermined algorithm. In a prospective group (group F, n = 6) a first therapy step with fibrinogen concentrate was added to the algorithm. The dose of fibrinogen concentrate was estimated by using thromboelastometric data (ROTEM FIBTEM). Before each step of hemostatic therapy, blood loss in the range of 60 to 250 g per 5 minutes was confirmed.

Results: In group F, administration of 7.8 +/- 2.7 g of fibrinogen concentrate established hemostasis, completely avoiding intraoperative transfusion of fresh frozen plasma and platelet concentrates. Transfusion of blood products after cardiopulmonary bypass and during the 24 hours after surgical intervention was markedly lower in group F than in group A (2.5 vs 16.4 units; 4/6 patients in group F required no transfusion of blood products), as was 24-hour drainage volume (449 vs 1092 mL). Fibrinogen plasma levels, standard coagulation parameters, and hemoglobin and hematocrit values were comparable between the 2 groups on the first postoperative day.

Conclusions: FIBTEM-guided post-cardiopulmonary bypass administration of fibrinogen concentrate resulted in improved intraoperative management of coagulopathic bleeding in thoracoabdominal aortic aneurysm operations and reduced transfusion and 24-hour drainage volume.

Citing Articles

On-Pump FIBTEM-A5 Accurately Predicts the A5 Values After Protamine Administration.

Vander Zwaag S, Tomko M, Madej T, Fassl J Anesthesiol Res Pract. 2025; 2025:2924468.

PMID: 39958621 PMC: 11824858. DOI: 10.1155/anrp/2924468.


Methodological Considerations for Studies Evaluating Bleeding Prediction Using Hemostatic Point-of-Care Tests in Cardiac Surgery.

Petricevic M, Goerlinger K, Milojevic M, Petricevic M J Clin Med. 2024; 13(22).

PMID: 39597881 PMC: 11595064. DOI: 10.3390/jcm13226737.


The Role of Viscoelastic Testing in Assessing Hemostasis: A Challenge to Standard Laboratory Assays?.

Reardon B, Pasalic L, Favaloro E J Clin Med. 2024; 13(12).

PMID: 38930139 PMC: 11205135. DOI: 10.3390/jcm13123612.


Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP/Haemocomplettan P).

Rahe-Meyer N, Neumann G, Schmidt D, Downey L Clin Appl Thromb Hemost. 2024; 30:10760296241254106.

PMID: 38803191 PMC: 11135097. DOI: 10.1177/10760296241254106.


TEG and ROTEM Traces: Clinical Applications of Viscoelastic Coagulation Monitoring in Neonatal Intensive Care Unit.

Cannata G, Mariotti Zani E, Argentiero A, Caminiti C, Perrone S, Esposito S Diagnostics (Basel). 2021; 11(9).

PMID: 34573982 PMC: 8465234. DOI: 10.3390/diagnostics11091642.